Quince Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -75.8% | -75.8% | -67.5% |
| FY2022 | -51.4% | -51.4% | -49.7% |
| FY2023 | -36.9% | -31.9% | -18.7% |
| FY2024 | -188.5% | -127.8% | -49.6% |
| FY2025 | 235.1% | 235.1% | -89.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -75.8% | -75.8% | -67.5% |
| FY2022 | -51.4% | -51.4% | -49.7% |
| FY2023 | -36.9% | -31.9% | -18.7% |
| FY2024 | -188.5% | -127.8% | -49.6% |
| FY2025 | 235.1% | 235.1% | -89.8% |